• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of biochemjBJ Latest papers and much more!
Biochem J. Nov 15, 2002; 368(Pt 1): 203–211.
PMCID: PMC1222952

Hepatocyte nuclear factor 4 response to injury involves a rapid decrease in DNA binding and transactivation via a JAK2 signal transduction pathway.

Abstract

The injury response is a complex set of events, which represents the reaction of a biological system to a perceived change in its environment in an attempt to maintain system integrity. Isolation of individual events or components of this response cannot describe the overall process, but may reflect general mechanisms that have evolved over time to solve the complex requirements of the injury response. The process, generally termed the acute phase response, is a series of organ-specific responses that begin shortly after a systemic injury. In the liver, this response involves both dramatic inductions and reductions in specific sets of genes, and an overall widespread global change in proteins produced. This can be thought of as a phenotypic change or 'reprogramming' of the liver. These changes in protein production are modulated and regulated at the level of transcription and involve significant manipulations of transcriptional regulatory mechanisms. Hepatocyte nuclear factor 4 (HNF-4) is a liver enriched transcription factor that regulates a large number of liver-specific genes, which play important roles in the critical pathways modulated by the response to injury. HNF-4 also performs an essential role in overall development and is critical for the normal expression of multiple genes in the developed liver, as well as being upstream of HNF-1 in a transcriptional hierarchy that drives hepatocyte differentiation. The role of HNF-4 in regulating liver-specific transcriptional changes directed by injury remains to be defined. In our cell-culture and whole-animal models, we demonstrate that the binding activity of HNF-4 decreases quickly after injury due to post-translational modification by phosphorylation. The mechanisms by which HNF-4 is modified after injury involve the activation of Janus kinase 2 (JAK2) signal transduction pathways, but the direct or indirect interaction of JAK2 with HNF-4 remains to be defined.

Full Text

The Full Text of this article is available as a PDF (252K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis. 1999;19(2):141–155. [PubMed]
  • Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39–48. [PubMed]
  • Jensen DE, Black AR, Swick AG, Azizkhan JC. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J Cell Biochem. 1997 Oct 1;67(1):24–31. [PubMed]
  • Kahn A. De la fonction glycogénique du foie à la régulation des gènes par le glucose. C R Seances Soc Biol Fil. 1998;192(5):813–827. [PubMed]
  • Kemper B. Regulation of cytochrome P450 gene transcription by phenobarbital. Prog Nucleic Acid Res Mol Biol. 1998;61:23–64. [PubMed]
  • Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994 Feb;15(2):74–80. [PubMed]
  • Sladek FM, Zhong WM, Lai E, Darnell JE., Jr Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990 Dec;4(12B):2353–2365. [PubMed]
  • Sladek FM. Orphan receptor HNF-4 and liver-specific gene expression. Receptor. 1993 Fall;3(3):223–232. [PubMed]
  • Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 2000 Feb 15;14(4):464–474. [PMC free article] [PubMed]
  • Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 1996 Feb;10(2):267–282. [PubMed]
  • Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001 Feb;21(4):1393–1403. [PMC free article] [PubMed]
  • Chaya D, Fougère-Deschatrette C, Weiss MC. Liver-enriched transcription factors uncoupled from expression of hepatic functions in hepatoma cell lines. Mol Cell Biol. 1997 Nov;17(11):6311–6320. [PMC free article] [PubMed]
  • Späth GF, Weiss MC. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol Cell Biol. 1997 Apr;17(4):1913–1922. [PMC free article] [PubMed]
  • Bulla GA. Selective loss of the hepatic phenotype due to the absence of a transcriptional activation pathway. Somat Cell Mol Genet. 1997 May;23(3):185–201. [PubMed]
  • Bulla GA. Hepatocyte nuclear factor-4 prevents silencing of hepatocyte nuclear factor-1 expression in hepatoma x fibroblast cell hybrids. Nucleic Acids Res. 1997 Jun 15;25(12):2501–2508. [PMC free article] [PubMed]
  • Burke PA, Drotar M, Luo M, Yaffe M, Forse RA. Rapid modulation of liver-specific transcription factors after injury. Surgery. 1994 Aug;116(2):285–293. [PubMed]
  • Burke PA, Luo M, Zhu J, Yaffe MB, Forse RA. Injury induces rapid changes in hepatocyte nuclear factor-1: DNA binding. Surgery. 1996 Aug;120(2):374–381. [PubMed]
  • Miquerol L, Lopez S, Cartier N, Tulliez M, Raymondjean M, Kahn A. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem. 1994 Mar 25;269(12):8944–8951. [PubMed]
  • Yanuka-Kashles O, Cohen H, Trus M, Aran A, Benvenisty N, Reshef L. Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors. Mol Cell Biol. 1994 Nov;14(11):7124–7133. [PMC free article] [PubMed]
  • Ray A, Ray BK. Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-beta and C/EBP-delta and their activation by phosphorylation. Mol Cell Biol. 1994 Jun;14(6):4324–4332. [PMC free article] [PubMed]
  • Viollet B, Kahn A, Raymondjean M. Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol. 1997 Aug;17(8):4208–4219. [PMC free article] [PubMed]
  • Bergot MO, Diaz-Guerra MJ, Puzenat N, Raymondjean M, Kahn A. Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP. Nucleic Acids Res. 1992 Apr 25;20(8):1871–1877. [PMC free article] [PubMed]
  • Burke PA, Hirschfeld S, Shirayoshi Y, Kasik JW, Hamada K, Appella E, Ozato K. Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J Exp Med. 1989 Apr 1;169(4):1309–1321. [PMC free article] [PubMed]
  • Baumann H, Richards C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol. 1987 Dec 15;139(12):4122–4128. [PubMed]
  • Wegenka UM, Buschmann J, Lütticken C, Heinrich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol. 1993 Jan;13(1):276–288. [PMC free article] [PubMed]
  • Chang CK, Moskal SF, 2nd, Srivenugopal KS, Schumer W. Altered levels of mRNA encoding enzymes of hepatic glucose metabolism in septic rats. Circ Shock. 1993 Sep;41(1):35–39. [PubMed]
  • Wang K, Deutschman CS, Clemens MG, De Maio A. Reciprocal expression of phosphoenolpyruvate carboxykinase and acute phase genes during acute inflammation. Shock. 1995 Mar;3(3):204–209. [PubMed]
  • Armstrong R, Wen W, Meinkoth J, Taylor S, Montminy M. A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A. Mol Cell Biol. 1995 Mar;15(3):1826–1832. [PMC free article] [PubMed]
  • Alam T, An MR, Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem. 1992 Mar 15;267(8):5021–5024. [PubMed]
  • Qian X, Samadani U, Porcella A, Costa RH. Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription. Mol Cell Biol. 1995 Mar;15(3):1364–1376. [PMC free article] [PubMed]
  • Flodby P, Antonson P, Barlow C, Blanck A, Porsch-Hällström I, Xanthopoulos KG. Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats. Exp Cell Res. 1993 Sep;208(1):248–256. [PubMed]
  • Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2207–2211. [PMC free article] [PubMed]
  • Wegner M, Cao Z, Rosenfeld MG. Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science. 1992 Apr 17;256(5055):370–373. [PubMed]
  • Metz R, Ziff E. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev. 1991 Oct;5(10):1754–1766. [PubMed]
  • Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkier M. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature. 1993 Aug 5;364(6437):544–547. [PubMed]
  • Trautwein C, van der Geer P, Karin M, Hunter T, Chojkier M. Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements. J Clin Invest. 1994 Jun;93(6):2554–2561. [PMC free article] [PubMed]
  • Ktistaki E, Ktistakis NT, Papadogeorgaki E, Talianidis I. Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9876–9880. [PMC free article] [PubMed]
  • Jiang G, Nepomuceno L, Yang Q, Sladek FM. Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch Biochem Biophys. 1997 Apr 1;340(1):1–9. [PubMed]
  • Marten NW, Sladek FM, Straus DS. Effect of dietary protein restriction on liver transcription factors. Biochem J. 1996 Jul 15;317(Pt 2):361–370. [PMC free article] [PubMed]
  • Rixen D, Siegel JH, Espina N, Bertolini M. Plasma nitric oxide in posttrauma critical illness: a function of "sepsis" and the physiologic state severity classification quantifying the probability of death. Shock. 1997 Jan;7(1):17–28. [PubMed]
  • Gourdon L, Lou DQ, Raymondjean M, Vasseur-Cognet M, Kahn A. Negative cyclic AMP response elements in the promoter of the L-type pyruvate kinase gene. FEBS Lett. 1999 Oct 1;459(1):9–14. [PubMed]
  • Aringer M, Cheng A, Nelson JW, Chen M, Sudarshan C, Zhou YJ, O'Shea JJ. Janus kinases and their role in growth and disease. Life Sci. 1999;64(24):2173–2186. [PubMed]
  • Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J. 1998 Sep 1;334(Pt 2):297–314. [PMC free article] [PubMed]
  • Zhu T, Lobie PE. Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J Biol Chem. 2000 Jan 21;275(3):2103–2114. [PubMed]
  • Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science. 1996 May 31;272(5266):1347–1349. [PubMed]
  • Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J. 1996 Mar;10(4):413–427. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...